Device Trial Radar · NCT03783039
The SURGICEL® Powder Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding (China Study)
Last checked: Nov 20, 2026Latest source record: Jul 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
234
Actual
Start
Jan 15, 2019
Primary completion
Dec 3, 2019
Study completion May 6, 2020
Sponsor
- Lead sponsor
- Ethicon, LLCPublic (JNJ)
- Sponsor type
- Industry
- First posted
- Dec 20, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a single blind, randomized, prospective study comparing SURGICEL Powder with SURGICEL Original (control arm) as an adjunct to achieve hemostasis in the control of capillary, venous, and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective during surgery (open, laparoscopic, or thoracoscopic) in Chinese adult subjects.
Conditions
- Hemorrhage
Interventions
SURGICEL PowderDevice
Surgeon to perform surgical procedure according to standard of care. If randomized to SURGICEL Powder, the product will be be applied to the first appropriate TBS with mild or moderate bleeding in parenchyma or soft tissue where conventional methods of control (i.e. suture, ligature, cautery) are ineffective or impractical.
SURGICEL OriginalDevice
Surgeon to perform surgical procedure according to standard of care. If randomized to SURGICEL Original, the product will be be applied to the first appropriate TBS with mild or moderate bleeding in parenchyma or soft tissue where conventional methods of control (i.e. suture, ligature, cautery) are ineffective or impractical.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hemostatic Success at 5 MinutesTime frame: From product application to 5 minutes following product application
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Zhejiang Provincial People's Hospital
Hangzhou, China
Jiangsu Province Hospital
Nanjing, China
Nanjing Drum Tower Hospital - Nanjing University Medical School
Nanjing, China
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.